Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1978 4
1979 2
1980 1
1981 1
1983 1
1985 2
1986 1
1987 1
1988 4
1989 3
1990 4
1991 4
1992 2
1993 2
1994 5
1995 6
1996 8
1997 7
1998 6
1999 5
2000 5
2001 10
2002 10
2003 4
2004 11
2005 10
2006 7
2007 7
2008 11
2009 5
2010 6
2011 17
2012 22
2013 19
2014 12
2015 14
2016 5
2017 11
2018 8
2019 19
2020 11
2021 17
2022 20
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

313 results

Results by year

Filters applied: . Clear all
Page 1
Immune thrombocytopenia.
Kistangari G, McCrae KR. Kistangari G, et al. Hematol Oncol Clin North Am. 2013 Jun;27(3):495-520. doi: 10.1016/j.hoc.2013.03.001. Hematol Oncol Clin North Am. 2013. PMID: 23714309 Free PMC article. Review.
Immune thrombocytopenia (ITP) is a common hematologic disorder characterized by isolated thrombocytopenia. ITP presents as a primary or a secondary form. ...
Immune thrombocytopenia (ITP) is a common hematologic disorder characterized by isolated thrombocytopenia. ITP presents as a p …
Diagnosis of monoclonal gammopathy of renal significance.
Bridoux F, Leung N, Hutchison CA, Touchard G, Sethi S, Fermand JP, Picken MM, Herrera GA, Kastritis E, Merlini G, Roussel M, Fervenza FC, Dispenzieri A, Kyle RA, Nasr SH; International Kidney and Monoclonal Gammopathy Research Group. Bridoux F, et al. Kidney Int. 2015 Apr;87(4):698-711. doi: 10.1038/ki.2014.408. Epub 2015 Jan 21. Kidney Int. 2015. PMID: 25607108 Free article. Review.
By definition, patients with MGRS do not meet the criteria for overt multiple myeloma/B-cell proliferation, and the hematologic disorder is generally consistent with monoclonal gammopathy of undetermined significance (MGUS). ...
By definition, patients with MGRS do not meet the criteria for overt multiple myeloma/B-cell proliferation, and the hematologic di
Tailored tyrosine kinase inhibitor (TKI) treatment of chronic myeloid leukemia (CML) based on current evidence.
Ciftciler R, Haznedaroglu IC. Ciftciler R, et al. Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):7787-7798. doi: 10.26355/eurrev_202112_27625. Eur Rev Med Pharmacol Sci. 2021. PMID: 34982440 Free article. Review.
Philadelphia (Ph*)/BCR-ABL1-positive chronic myeloid leukemia (CML) is a neoplastic hematologic disorder, which is a functionally curable chronic disease via using tyrosine kinase inhibitor (TKI) drugs. ...
Philadelphia (Ph*)/BCR-ABL1-positive chronic myeloid leukemia (CML) is a neoplastic hematologic disorder, which is a functiona …
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia.
Roboz GJ, DiNardo CD, Stein EM, de Botton S, Mims AS, Prince GT, Altman JK, Arellano ML, Donnellan W, Erba HP, Mannis GN, Pollyea DA, Stein AS, Uy GL, Watts JM, Fathi AT, Kantarjian HM, Tallman MS, Choe S, Dai D, Fan B, Wang H, Zhang V, Yen KE, Kapsalis SM, Hickman D, Liu H, Agresta SV, Wu B, Attar EC, Stone RM. Roboz GJ, et al. Blood. 2020 Feb 13;135(7):463-471. doi: 10.1182/blood.2019002140. Blood. 2020. PMID: 31841594 Free PMC article. Clinical Trial.
Median age was 76.5 years, 26 patients (76%) had secondary AML, and 16 (47%) had received 1 hypomethylating agent for an antecedent hematologic disorder. The most common all-grade adverse events were diarrhea (n = 18; 53%), fatigue (n = 16; 47%), nausea (n = 13; 38% …
Median age was 76.5 years, 26 patients (76%) had secondary AML, and 16 (47%) had received 1 hypomethylating agent for an antecedent hemat
Paraproteinemic neuropathies.
Raheja D, Specht C, Simmons Z. Raheja D, et al. Muscle Nerve. 2015 Jan;51(1):1-13. doi: 10.1002/mus.24471. Epub 2014 Nov 22. Muscle Nerve. 2015. PMID: 25288371 Review.
Treatments may be aimed specifically at the neuropathy, or against the underlying hematologic disorder. In all patients with paraproteinemias, the neurologist can work collaboratively with the hematologist to formulate therapeutic plans and goals and can provide fol …
Treatments may be aimed specifically at the neuropathy, or against the underlying hematologic disorder. In all patients with p …
Monoclonal Gammopathy-Related Kidney Diseases.
Sy-Go JPT, Herrmann SM, Seshan SV. Sy-Go JPT, et al. Adv Chronic Kidney Dis. 2022 Mar;29(2):86-102.e1. doi: 10.1053/j.ackd.2022.01.004. Adv Chronic Kidney Dis. 2022. PMID: 35817530 Review.
Overall, the treatment is directed against the underlying hematologic disorder and the potential source of the monoclonal protein....
Overall, the treatment is directed against the underlying hematologic disorder and the potential source of the monoclonal prot …
Paraproteinemic neuropathy.
Zivković SA, Lacomis D, Lentzsch S. Zivković SA, et al. Leuk Lymphoma. 2009 Sep;50(9):1422-33. doi: 10.1080/10428190903111922. Leuk Lymphoma. 2009. PMID: 19637090 Review.
Therapy is mostly based on the treatment of the underlying hematologic disorder. Risks and benefits should be carefully evaluated as treatment may be associated with considerable morbidity. ...
Therapy is mostly based on the treatment of the underlying hematologic disorder. Risks and benefits should be carefully evalua …
Cold agglutinin disease.
Swiecicki PL, Hegerova LT, Gertz MA. Swiecicki PL, et al. Blood. 2013 Aug 15;122(7):1114-21. doi: 10.1182/blood-2013-02-474437. Epub 2013 Jun 11. Blood. 2013. PMID: 23757733 Free article. Review.
The most common symptom was acrocyanosis (n = 39 [44%]), and many had symptoms triggered by cold (n = 35 [39%]) or other factors (n = 20 [22%]). An underlying hematologic disorder was detected in 69 patients (78%). Thirty-six patients (40%) received transfusions dur …
The most common symptom was acrocyanosis (n = 39 [44%]), and many had symptoms triggered by cold (n = 35 [39%]) or other factors (n = 20 [22 …
Thrombocytopenia.
Gauer RL, Braun MM. Gauer RL, et al. Am Fam Physician. 2012 Mar 15;85(6):612-22. Am Fam Physician. 2012. PMID: 22534274 Free article.
These patients most likely have an acute infection, heparin-induced thrombocytopenia, liver disease, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, disseminated intravascular coagulation, or a hematologic disorder. During pregnancy, preeclampsia and …
These patients most likely have an acute infection, heparin-induced thrombocytopenia, liver disease, thrombotic thrombocytopenic purpura/hem …
Paraproteinemic neuropathies.
Mauermann ML. Mauermann ML. Continuum (Minneap Minn). 2014 Oct;20(5 Peripheral Nervous System Disorders):1307-22. doi: 10.1212/01.CON.0000455879.99050.26. Continuum (Minneap Minn). 2014. PMID: 25299284 Review.
Optimal management of paraproteinemic neuropathies requires appropriate evaluation of the monoclonal protein for an underlying hematologic disorder. RECENT FINDINGS: Clinical studies in paraproteinemic neuropathies have provided a better understanding of these disor …
Optimal management of paraproteinemic neuropathies requires appropriate evaluation of the monoclonal protein for an underlying hematologi
313 results